{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:55:12Z","timestamp":1787165712250,"version":"build-2736575974"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Leber\u2019s hereditary optic neuropathy (LHON) is a maternally inherited condition due to mitochondrial DNA (mtDNA) mutations usually affecting young men within their thirties, while women seem protected by estrogens with a female-to-male ratio of 1:3. Late-onset cases (over 40\u202fyears of age) are usually associated to toxic exposure to tobacco smoke or drugs causing mitochondrial dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We describe two cases of LHON remarkable for their late onset (&amp;gt; 60\u202fyears) in the absence of classic toxic factors. They were both affected by advanced prostate cancer and developed LHON after introduction of enzalutamide, an antagonist of androgens\u2019 receptor, in association with leuprolide, a gonadotropin-releasing hormone (GnRH) analogue, used in the context of Androgen deprivation therapy (ADT). Both patients presented very low serum levels of gonadotropin, estrogens and androgens compatible with hormonotherapy. MtDNA copy number in our probands resulted significantly reduced (like other LHON affected cases), compared to age-matched LHON unaffected mutation carriers and controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The role of hormones in LHON pathogenesis remains still debated. Recent evidence suggests a protective effect of estrogens in increasing mitochondrial biogenesis (and mtDNA copy number), partially explaining the gender bias of the disease, while the role of androgens is yet to be fully understood. Considering the effect of the ADT on circulating hormonal levels and their reciprocal interactions, we hypothesize that in a context of already low estrogens levels due to GnRH analogue, the block of androgens receptors by Leuprolide further imbalance the estrogens to androgens ratio and eventually trigger the disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1616992","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:51:10Z","timestamp":1755150670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Late-onset Leber\u2019s hereditary optic neuropathy and antiandrogens for prostate cancer: is there a causative link?"],"prefix":"10.3389","volume":"16","author":[{"given":"Giulia","family":"Amore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Carbonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"D\u2019Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Faustini-Fustini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Maresca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Carelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"La Morgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3390\/biomedicines10081930","article-title":"Leber hereditary optic neuropathy: molecular pathophysiology and updates on gene therapy","volume":"10","author":"Chi","year":"2022","journal-title":"Biomedicines"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"8626","DOI":"10.3390\/ijms25168626","article-title":"Mitochondria in retinal ganglion cells: unraveling the metabolic Nexus and oxidative stress","volume":"25","author":"Yang","year":"2024","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbabio.2004.05.009","article-title":"Bioenergetics shapes cellular death pathways in Leber\u2019s hereditary optic neuropathy: a model of mitochondrial neurodegeneration","volume":"1658","author":"Carelli","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1093\/brain\/awv339","article-title":"Parsing the differences in affected with LHON: genetic versus environmental triggers of disease conversion","volume":"139","author":"Carelli","year":"2016","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2019.11.014","article-title":"Demographics of a large international population of patients affected by Leber\u2019s hereditary optic neuropathy","volume":"127","author":"Poincenot","year":"2020","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/brain\/awq276","article-title":"Oestrogens ameliorate mitochondrial dysfunction in Leber\u2019s hereditary optic neuropathy","volume":"134","author":"Giordano","year":"2011","journal-title":"Brain J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/brain\/awt343","article-title":"Efficient mitochondrial biogenesis drives incomplete penetrance in Leber\u2019s hereditary optic neuropathy","volume":"137","author":"Giordano","year":"2014","journal-title":"Brain J Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1093\/hmg\/ddv396","article-title":"Targeting estrogen receptor \u03b2 as preventive therapeutic strategy for Leber\u2019s hereditary optic neuropathy","volume":"24","author":"Pisano","year":"2015","journal-title":"Hum Mol Genet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"101437","DOI":"10.1016\/j.xcrm.2024.101437","article-title":"Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial","volume":"5","author":"Yu-Wai-Man","year":"2024","journal-title":"Cell Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40265-020-01428-3","article-title":"Therapeutic options in hereditary optic neuropathies","volume":"81","author":"Amore","year":"2021","journal-title":"Drugs"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/01.aids.0000186019.47297.0d","article-title":"Effect of treatment interruption monitored by CD4 cell count on mitochondrial DNA content in HIV-infected patients: a prospective study","volume":"19","author":"Mussini","year":"2005","journal-title":"AIDS"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.steroids.2015.08.002","article-title":"The estrogenic retina: the potential contribution to healthy aging and age-related neurodegenerative diseases of the retina","volume":"103","author":"Cascio","year":"2015","journal-title":"Steroids"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jcb.21936","article-title":"Estrogenic control of mitochondrial function and biogenesis","volume":"105","author":"Klinge","year":"2008","journal-title":"J Cell Biochem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fnagi.2018.00124","article-title":"Mitochondria, estrogen and female brain aging","volume":"10","author":"Lejri","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fendo.2018.00066","article-title":"Gonadal hormones and retinal disorders: a review","volume":"9","author":"Nuzzi","year":"2018","journal-title":"Front Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1021\/mp400313u","article-title":"17\u03b2-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma","volume":"10","author":"Prokai-Tatrai","year":"2013","journal-title":"Mol Pharm"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/dneu.20373","article-title":"Retinal ganglion cell protection by 17-beta-estradiol in a mouse model of inherited glaucoma","volume":"67","author":"Zhou","year":"2007","journal-title":"Dev Neurobiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.joco.2018.10.003","article-title":"Hormone replacement therapy in Leber\u2019s hereditary optic neuropathy: accelerated visual recovery in vivo","volume":"31","author":"Fantini","year":"2019","journal-title":"J Curr Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199707103370204","article-title":"Effect of testosterone and estradiol in a man with aromatase deficiency","volume":"337","author":"Carani","year":"1997","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/eje.0.1400111","article-title":"Oestrogen deficiency in men: where are we today?","volume":"140","author":"Faustini-Fustini","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/aja202212","article-title":"Associations of sex hormone levels with body mass index (BMI) in men: a cross-sectional study using quantile regression analysis","volume":"25","author":"Lv","year":"2023","journal-title":"Asian J Androl"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"C835","DOI":"10.1152\/ajpcell.00205.2022","article-title":"Role of androgens and androgen receptor in control of mitochondrial function","volume":"323","author":"Ahmad","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s13353-020-00550-y","article-title":"Testosterone increases apoptotic cell death and decreases mitophagy in Leber\u2019s hereditary optic neuropathy cells","volume":"61","author":"Jankauskait\u0117","year":"2020","journal-title":"J Appl Genet"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.18632\/aging.203153","article-title":"Testosterone ameliorates age-related brain mitochondrial dysfunction","volume":"13","author":"Yan","year":"2021","journal-title":"Aging"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat Metab"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"6666","DOI":"10.3390\/molecules27196666","article-title":"Enzalutamide induces apoptotic insults to human drug-resistant and -sensitive glioblastoma cells via an intrinsic Bax-mitochondrion-cytochrome C caspase Cascade activation pathway","volume":"27","author":"Chang","year":"2022","journal-title":"Molecules"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1038\/s41467-020-16126-7","article-title":"2,4-dienolyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer","volume":"11","author":"Blomme","year":"2020","journal-title":"Nat Commun"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1616992\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T05:51:11Z","timestamp":1755150671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1616992\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":27,"alternative-id":["10.3389\/fneur.2025.1616992"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1616992","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"article-number":"1616992"}}